Archives for December 17, 2018

← 2018
2018: An inflection point for generics

Q&A

2018: An inflection point for generics

By Flora Southey

Generics drug portfolios are diversifying, prices are stabilising, and while competition remains intense, the worst of price erosion appears to be over, claims Clarivate Analytics executive.